Literature DB >> 316572

Receptors for IgM on human lymphoblastoid B and T cell lines.

J L Preud'homme, M Gonnot, M Fellous, M Seligmann.   

Abstract

Receptors for the Fc of IgM were studied together with other lymphocyte markers on cells from nineteen human lymphoblastoid cell lines. Receptors for IgM were found on three of seven T lines and three of twelve B lines studied. Culture conditions needed for an optimal detection of the receptor were different for B and T lines. The presence of the receptor for IgM could not be correlated with that of any other membrane marker.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 316572     DOI: 10.1111/j.1365-3083.1979.tb01341.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  Characterization of the Fc(IgG) receptor on the pluripotential leukaemia cell K-562.

Authors:  A T Ichiki; C J Wust; C B Lozzio
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

2.  Specificity and polymorphism of diaminopeptidase IV in normal and neoplastic T mu lymphocytes.

Authors:  A C Feller; M R Parwaresch
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

3.  Specific receptors for the serum thymic factor (FTS) in lymphoblastoid cultured cell lines.

Authors:  J M Pléau; V Fuentes; J L Morgat; J F Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

4.  The glycosidic antigen recognised by a novel monoclonal antibody, 75.12, is developmentally regulated on mouse embryonal carcinoma cells.

Authors:  C Blaineau; J Le Pendu; D Arnaud; F Connan; P Avner
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

5.  'Attached cell' antigen 28.3.7 mapping to human chromosome 15 characterises TPA-induced differentiation of the promyelocytic HL-60 cell line to give macrophage/monocyte populations.

Authors:  C Blaineau; P Avner; A Tunnacliffe; P Goodfellow
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.